Back to News
Market Impact: 0.45

UAMY vs. TMC: A Faceoff Between Two Emerging Critical Minerals Strategies

UAMY
Commodities & Raw MaterialsCompany FundamentalsCorporate EarningsRegulation & LegislationTrade Policy & Supply ChainTechnology & InnovationInfrastructure & DefenseAnalyst Insights
UAMY vs. TMC: A Faceoff Between Two Emerging Critical Minerals Strategies

United States Antimony (UAMY) is showing near-term operational traction with H1 2025 revenue up 160% to $17.5m and nine‑month revenue of $26.2m (up 182%), gross margin expansion to ~28%, cash and investments of $38.5m and the restart of domestic antimony mining at Stibnite Hill with bulk samples >10% Sb. The Metals Company (TMC) remains a development-stage deep‑sea nodules play with no recent revenue but published PFS/IA studies implying a combined NPV >$23bn, liquidity of $165m plus >$400m potential from warrants, and an aim toward commercial recovery in Q4 2027; management projects long‑run EBITDA margins near 50% as refining scales. Both firms advance U.S. critical‑minerals supply‑chain goals but present divergent risk/reward profiles: UAMY with immediate cashflow and government demand alignment, TMC with long‑cycle capital and regulatory execution risk.

Analysis

Contrarian angles: Consensus underprices de‑risking value in U.S. processing incumbents—if UAMY secures a DLA off‑take within 6–12 months, upside could re‑rate multiples 2x from current depressed levels; conversely, market may be overenthusiastic about TMC’s timeline—commercial recovery by Q4 2027 assumes smooth permitting and capex that historically take +18 months to secure. Historical parallels: rare‑metal restarts (e.g., US tungsten in 1970s/80s) saw lumpy cashflows and sudden permit setbacks—expect lumpy news and position sizing accordingly. Unintended consequence: rapid US domesticization could invite export controls or subsidy conditionality that compresses margins and complicates off‑taker agreements.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo